Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Maillard

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Metallomics : Integrated Biometal Science|October 25, 2013
Metal sensing and signal transduction by CnrX from Cupriavidus metallidurans CH34: role of the only methionine assessed by a functional, spectroscopic, and theoretical studyJuliette Trepreau, Cornelia Grosse, Jean-Marie Mouesca, et al.
Nucleic Acids Research|October 13, 2007
Idiosyncratic features in tRNAs participating in bacterial cell wall synthesisRégis Villet, Matthieu Fonvielle, Patricia Busca, et al.
AJNR. American Journal of Neuroradiology|April 28, 2012
The contributions of MRI-based measures of gray matter, white matter hyperintensity, and white matter integrity to late-life cognitionJ He, V S S Wong, E Fletcher, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
Sexually dimorphic differences in angiogenesis markers predict brain aging trajectoriesA Torres-Espin, Hannah Rabadaugh, S Fitzsimons, et al.
Blood Advances|May 4, 2022
Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemiaAndrew H Matthews, Alexander E Perl, Selina M Luger, et al.
American Journal of Hematology|June 19, 2023
Real-world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemiaAndrew H Matthews, Alexander E Perl, Selina M Luger, et al.
Nature Medicine|May 21, 2021
CD8<sup>+</sup> T cells contribute to survival in patients with COVID-19 and hematologic cancerErin M Bange, Nicholas A Han, Paul Wileyto, et al.
Research Square|February 10, 2021
CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancerErin M Bange, Nicholas A Han, Paul Wileyto, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Metallomics : Integrated Biometal Science|October 25, 2013
Metal sensing and signal transduction by CnrX from Cupriavidus metallidurans CH34: role of the only methionine assessed by a functional, spectroscopic, and theoretical studyJuliette Trepreau, Cornelia Grosse, Jean-Marie Mouesca, et al.
Nucleic Acids Research|October 13, 2007
Idiosyncratic features in tRNAs participating in bacterial cell wall synthesisRégis Villet, Matthieu Fonvielle, Patricia Busca, et al.
AJNR. American Journal of Neuroradiology|April 28, 2012
The contributions of MRI-based measures of gray matter, white matter hyperintensity, and white matter integrity to late-life cognitionJ He, V S S Wong, E Fletcher, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
Sexually dimorphic differences in angiogenesis markers predict brain aging trajectoriesA Torres-Espin, Hannah Rabadaugh, S Fitzsimons, et al.
Blood Advances|May 4, 2022
Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemiaAndrew H Matthews, Alexander E Perl, Selina M Luger, et al.
American Journal of Hematology|June 19, 2023
Real-world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemiaAndrew H Matthews, Alexander E Perl, Selina M Luger, et al.
Nature Medicine|May 21, 2021
CD8<sup>+</sup> T cells contribute to survival in patients with COVID-19 and hematologic cancerErin M Bange, Nicholas A Han, Paul Wileyto, et al.
Research Square|February 10, 2021
CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancerErin M Bange, Nicholas A Han, Paul Wileyto, et al.
Pageof 9